Liu S, Chen H, Gagea M, Federico L, et al. ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy. Cancer Lett 2025 May 6:217775. doi: 10.1016/j.canlet.2025.217775.
PMID: 40339955